Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mometasone/glycopyrronium/indacaterol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Enerzair Breezhaler 114microg / 46microg / 136microg/dose
0302000W0BBAAAA
|
Enerzair | Mometasone/glycopyrronium/indacaterol | Respiratory System | 5,554 |
|
Generic Enerzair Breezhaler 114/46/136microg inh caps + dev
0302000W0AAAAAA
|
Mometasone/glycopyrronium/indacaterol | Mometasone/glycopyrronium/indacaterol | Respiratory System | 13 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.